AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.840
+0.050 (1.79%)
Mar 9, 2026, 2:50 PM EDT - Market open
AC Immune Market Cap
AC Immune has a market cap or net worth of $281.00 million as of March 9, 2026. Its market cap has increased by 5.80% in one year.
Market Cap
281.00M
Enterprise Value
145.87M
1-Year Change
5.80%
Ranking
Category
Stock Price
$2.84
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $281.00M, a decrease of -67.61%. That is a compound annual growth rate of -11.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 281.50M | -11.14% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 289.95M |
| Aldeyra Therapeutics | 288.88M |
| Context Therapeutics | 286.66M |
| OmniAb | 273.64M |
| Coherus Oncology | 272.04M |
| Enlivex | 270.61M |
| Prelude Therapeutics | 266.14M |
| Cellectis | 265.08M |